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ABSTRACT
Background: Japanese cedar pollen-induced allergic rhinitis in a guinea pig model clearly induced not only
sneezing but also biphasic nasal blockage. To date, there have only been a few reports on models of murine al-
lergic rhinitis which clearly show nasal blockage. Therefore, in order to try and develop such a model, we ad-
ministered multiple dosages of intranasal pollen or purified antigen protein Cry j 1.
Methods: B10.S mice were sensitized by intranasal instillations of either pollen extract or Cry j 1 twice a day
for 7 days, which was adsorbed on Al(OH)3. Subsequently, once a week, the mice were given multiple intrana-
sal instillation challenges of either the pollen suspension or Cry j 1 and the frequency of sneezing was observed
after respective challenges were made. Specific airway resistance (sRaw) was measured as an indicator for
nasal blockage. Cry j 1-specific IgE levels were measured using an enzyme-linked immunosorbent assay.
Results: The serum Cry j 1-specific IgE level showed clear elevation only in the group sensitized by Cry j 1 +
Al(OH)3 and then challenged by Cry j 1. No elevations were seen in the groups sensitized by pollen extract + Al
(OH)3 followed by a pollen suspension challenge. There was an immediate increase in sneezing after chal-
lenges in all of the sensitized-challenged groups. Nevertheless, no increases in sRaw in any of the groups were
detected at any of the time points during the 8 hours following the challenges.
Conclusions: Cry j 1 may be more effective than crude antigens for efficient sensitizationchallenge in mice.
No increase in sRaw occurred, even in mice that possessed high amounts of Cry j 1-specific IgE and that ex-
hibited sneezing.
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INTRODUCTION
We established a guinea pig model of Japanese cedar
pollen-induced allergic rhinitis.1-3 In this model,
sneezing was immediately induced, and nasal block-
age, the most serious symptom for allergic rhinitis
patients, was biphasically caused after a pollen inhala-
tion challenge.2 We analyzed the induction mecha-
nisms underlying the allergic nasal symptoms.4-6
Similar to our model, other groups have also reported
that sensitized guinea pigs show not only sneezing
but also biphasic nasal blockage after challenges with
the allergen ovalbumin (OVA).7-9
Mice have provided excellent models for analyzing
the mechanisms of inflammatory diseases, as many
immunological tools and gene-modified animals are
available for testing this system. In murine allergic
rhinitis models, incidence of sneezing and nasal rub-
bing, increased sneezing as a response to histamine,
infiltration of eosinophils into the nasal mucosa and
Th2 cytokine production, have been observed as al-
lergic symptom parameters in the upper airway.10-14 It
has remained unclear until recently, whether nasal
blockage was induced after an intranasal challenge
with an antigen in mice. However, Miyahara15,16 has
reported that intranasal OVA challenge caused an
early phase nasal blockage that peaked at 4―10 min-
utes after the challenge, along with an increase in na-
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sal airway resistance that was present even at 24
hours in anesthetized mice.
Japanese cedar pollen, which is one of the most
common allergens that induces pollenosis in Japan,
contains 2 major antigenic proteins, Cry j 117 and Cry
j 2.18 It has been reported that in each of the antigenic
proteins, there are 10 different T-cell epitopes that are
active in patients with Japanese cedar pollenosis.19 A
major T-cell epitope has been identified in Cry j 1-
sensitized B10.S mice,20 and this epitope sequence
coincides with the most prevalent epitope in patients.
Therefore, it was suggested that the B10.S mouse
would be a suitable strain for Japanese cedar pollen-
associated diseases. Using B10.S mice sensitized by
i.p. injections with Cry j 1 + Al(OH)3, Tsunematsu et
al.21,22 were able to create a murine model of pollen-
induced allergic rhinitis, in which the animals exhib-
ited sneezing, eosinophil recruitment in nasal tissue
and the production of serum Cry j 1-specific IgE after
multiple intranasal challenges with Cry j 1. However,
to date there have been no reports on whether nasal
blockage can also be induced in a murine Japanese
cedar pollen-induced allergic rhinitis model.
In the present study, we used B10.S mice to assess
whether nasal blockage is caused in an allergic rhini-
tis model induced by pollen. In order to mimic as
closely as possible the sensitizationchallenge situ-
ations that can be seen in a clinical setting, mice were
sensitized by multiple intranasal instillations of either
a pollen extract + Al(OH)3 or Cry j 1 + Al(OH)3, fol-
lowed by repetitive challenges to animals with in-
tranasal applications of either the pollen suspension
or Cry j 1. In addition to monitoring the incidence of
sneezing and the serum Cry j 1-specific IgE produc-
tion, we also examined the increases in specific air-
way resistance (sRaw), which is a parameter of nasal
blockage. Since sRaw has been used as a reliable in-
dicator for nasal blockage in guinea pig models of al-
lergic rhinitis,2-6 this makes it possible to longitudi-
nally measure the changes in airway resistance with-
out having to employ any anesthesia or perform any
surgical operations.
METHODS
ANIMALS
Five-week-old female B10.S mice were purchased
from Japan SLC (Hamamatsu, Japan). The animals
were housed in an air-conditioned room at a tempera-
ture of 23 ± 1℃ and 60 ± 10% humidity with the lights
turned on from 8:00 a.m. to 8:00 p.m. Animals were
given a standard laboratory diet and water ad libitum.
The first sensitization procedure was initiated 1 week
after the arrival of the mice.
This animal study was approved by the Experimen-
tal Animal Research Committee at Kyoto Pharmaceu-
tical University.
ANTIGEN AND ADJUVANT
Japanese cedar (Cryptomeria japonica) pollen was
harvested in Gifu and Shiga prefectures (Japan) in
1998. Purified Cry j 1 was provided by Meiji Dairies
Co. (Odawara, Japan). Al(OH)3 gels were prepared
with 0.25 N NaOH and 0.25 N Al2(SO4)3, as our group
previously described.23
The cedar pollen extract used for the sensitization
was prepared as follows. The pollen was suspended
in PBS followed by vigorous stirring for more than 30
minutes. The suspension was then centrifuged, and
the supernatant was collected. Protein concentration
in the supernatant was measured using the method of
Bensadoun and Weinstein.24
SENSITIZATION AND CHALLENGE
Experiment 1 (Fig. 1)
The pollen-induced allergic rhinitis model in guinea
pigs2-6 served as the basis for determining the dosage
of pollen extract and Al(OH)3 that were used for sen-
sitization in the mice. Based on body weight, the
doses were decreased to 115 of the dosage used in
the guinea pig model. Twice a day for 7 days, the
mice were sensitized by bilateral intranasal instilla-
tion of the cedar pollen extract adsorbed onto
Al(OH)3 gel at a concentration of 0.02 μg protein0.02
mg Al(OH)32 μleach nostril. Prior to each sensitiza-
tion, the upper airway mucosal surface was anesthe-
tized by inhaling a mist of 4% lidocaine hydrochloride
solution (Fujisawa Pharm. Co., Osaka, Japan) for 3
minutes, which was generated by an ultrasonic nebu-
lizer (NE-U12, Omron, Osaka, Japan). The airway
was anesthetized in order to prevent the rapid elimi-
nation of the antigen by ciliary movement.
Two weeks after the first sensitization, the sensi-
tized animals were then intranasally challenged with
a pollen suspension at a dosage of 90 μg2 μlnostril
(180 μganimal) once every week until the 15th chal-
lenge (Group 1A).
Experiment 2 (Fig. 1)
In the second group, mice were intranasally sensi-
tized with a 50-fold higher dosage of the extract +
Al(OH)3 which was used in Group 1A (1 μg protein
0.1 mg Al(OH)32 μleach nostriltime, Groups 2A
and 2B). In addition, in place of the pollen extract, pu-
rified Cry j 1 + Al(OH)3 was used for sensitization at 1
μg Cry j 10.1 mg Al(OH)32 μleach nostriltime
(Groups 2C and 2D). We have previously reported
that approximately 80% of protein in the extract is Cry
j 1.25 Sensitizations were carried out by following the
same schedule that was used in Experiment 1.
Two weeks after the first sensitization, the mice
were then intranasally challenged with the pollen sus-
pension at 90 μg2 μlnostril (180 μgmouse) once
every week until the 15th challenge (Groups 2A and
2C). Alternatively, Cry j 1 was used as a challenging
antigen at a dosage of 2 μg2 μlnostril (4 μgmouse)
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Fig. 1 Schedule for intranasal sensitization, using either Japanese cedar polen extract or Cry j 1, and 
the subsequent nasal chalenges with intranasal administrations of either the polen suspension or Cry j 
1 in mice. ＊ :0.02 μg protein/0.02 mg Al(OH)3/2 μl/nostril/time, ＊＊ :1 μg protein/0.1 mg Al(OH)3/2 
μl/nostril/time, ＊＊＊ :1 μg Cry j 1/0.1 mg Al(OH)3/2 μl/nostril/time, † :90 μg/2 μl/nostril, †† :2 μg/2 
μl/nostril.
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Pollen extract
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†
(1) (2) (3) (4) (5) (14) (15) Group 2A (Time ofinstillation)Pollen extract
㧗AI(OH)3 (High dose
㧖㧖) Pollen suspension
†
(1) (2) (3) (4) (5) (14) (15) Group 2B (Time ofinstillation)Pollen extract
㧗AI(OH)3 (High dose
㧖㧖) Cry j 1
††
(1) (2) (3) (4) (5) (14) (15) Group 2C (Time ofinstillation)Cry j 1
㧗AI(OH)3
㧖㧖㧖 Pollen suspension†
(1) (2) (3) (4) (5) (14) (15) Group 2D (Time ofinstillation)Cry j 1
㧗AI(OH)3
㧖㧖㧖 Cry j 1††
(Groups 2B and 2D). From our previous report25 we
were able to calculate that the amount of Cry j 1 in 90
μg of pollen was approximately 55 ng, and therefore
the dosage (2 μgnostril) for Cry j 1 used in Groups 2
B and 2D was higher than the amount contained in
the 90 μg-weight pollen suspension used in Groups 2
A and 2C.
For the negative control groups, non-sensitized
mice were intranasally treated with PBS (Group NS-
NC) or the pollen extract with a dosage of 90 μg2
μlnostril (Group NS-C) according to the schedule
described above.
MEASURING SNEEZING FREQUENCY
The frequency of sneezing was measured during the
first hour after pollen challenges were made.
MEASUREMENT OF SPECIFIC AIRWAY RESIS-
TANCE (sRaw)
sRaw was used as an indicator for nasal blockage. A
two-chambered, double-flow plethysmograph system
along with a data analyzer Pulmos-I (MIPS, Osaka, Ja-
pan) were used to measure the sRaw as by the
method of Pennock et al.26
MEASUREMENT OF Cry j 1-SPECIFIC IgE ANTI-
BODY IN SERA
Cry j 1-specific IgE antibody was determined by an
enzyme-linked immunosorbent assay (ELISA) using
blood samples collected 1 day before the challenges.
In brief, the wells of an ELISA plate (Immulon 4HBX,
Thermo Labsystems, Milford, MA, USA) were coated
with 2 μgml of Cry j 1 by incubation at 4℃ for 12―18
hours. After the wells were washed, they were
treated with a blocking buffer of 10% fetal bovine
serum-containing PBS, for 2 hours at room tempera-
ture. Subsequently, diluted sample sera were added
and then allowed to stand at 4℃. The following day,
the plate was washed, and biotin-conjugated rat anti-
mouse IgE (BD Pharmingen, San Diego, CA, USA)
was added at 2 μgml. Avidin-horseradish peroxidase
conjugate (1 : 1000, BD Pharmingen) was added 1
hour after being washed, and the plate was then al-
lowed to stand at room temperature for 30 minutes.
After washing, the enzyme reaction was initiated by
addition of a substrate, 3,3’,5,5’-tetramethylbenzidine
(Sigma Chem., St. Louis, MO, USA). The reaction
was terminated by adding a sulfuric acid solution 30
minutes after the onset of the reaction. A microplate
reader was used to measure absorbance at 450 nm,
with the amount of Cry j 1-specific IgE (arbitrary unit
(au)ml) then calculated from a standard curve. The
standard curve values were obtained from pooled
anti-Cry j 1 mouse serum that had been prepared in
advance by sensitizing B10.S mice with multiple in-
traperitoneal injections of the pollen extract + Al(OH)3
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Fig. 2 (A) Induction of sneezing, (B) time-course changes in specific airway resistance (sRaw) 
after the 15th instilation chalenge with Japanese cedar polen suspension in sensitized mice 
(Group 1A) and (C) time-course changes in amount of Cry j 1-specific IgE during chalenges with 
the polen suspension (Group 1A). Each column or point represents the mean ± S.E. of 5―10 
animals.
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at a dosage of 20 μg protein20 mg Al(OH)3250 μl
animaltime once a week for a total of 8 times.
STATISTICAL ANALYSES
Statistical analysis was performed by using a one-way
analysis of variance. If significant differences were de-
tected, individual group differences were determined
using Bonferroni’s multiple test. A probability value
(P) of less than 0.05 was considered to indicate a sta-
tistically significant difference.
RESULTS
SNEEZING, NASAL BLOCKAGE AND IgE PRO-
DUCTION IN LOW DOSAGE POLLEN EXTRACT-
SENSITIZED MICE (EXPERIMENT 1)
Mice were intranasally sensitized with the pollen ex-
tract + Al(OH)3, followed by challenges with the pol-
len suspension once a week until the 15th challenge
(Group 1A). The experimental protocol and schedule
were based on the results obtained from our previous
studies conducted on the guinea pig model of allergic
rhinitis.2-6 After the 15th challenge, there was an in-
crease in induced sneezing of approximately 15
timeshour, although no increase in sRaw was indi-
cated. Cry j 1-specific IgE slightly increased 1 day be-
fore the 15th challenge (Fig. 2).
SNEEZING, NASAL BLOCKAGE AND IgE PRO-
DUCTION IN EITHER HIGH DOSAGE POLLEN
EXTRACT- OR CRY J 1-SENSITIZED MICE (EX-
PERIMENT 2)
Based on the results of Experiment 1, the dosage of
the pollen extract for sensitization was increased
(Groups 2A and 2B). In addition, Cry j 1 was used as
the sensitization (Groups 2C and 2D) and the chal-
lenging (Groups 2B and 2D) antigen. As shown in
Figure 3, mice sensitized with either the extract +
Al(OH)3 or Cry j 1 + Al(OH)3 showed increased fre-
quencies of sneezing within 1 hour after the 1st chal-
lenge when exposed to either the pollen suspension
(Groups 2A and 2C) or Cry j 1 (Groups 2B and 2D).
The frequency of sneezing increased even more at
the 5th, 8th, and 13th challenges. When non-
sensitized mice were intranasally instilled with the
pollen extract at the time corresponding to the 13th
challenge, sneezing was induced by <1 timehour.
Figure 4 represents the time-course changes in
sRaw after the 1st, 5th and 15th challenges in Groups
NS-NC, 2A, 2B, 2C, and 2D. On the 1st and 5th chal-
lenges, no increase in sRaw was detected after the
challenges in any of the groups at any time point dur-
ing the 0―8 hour time period. At the 15th challenge,
elevations of sRaw were noted in all groups, including
the NS-NC Group, at 20 minutes after the challenge.
Figure 5 shows the time-course changes occurring
in the amount of Cry j 1-specific IgE antibody in the
sera during the repetitive antigen challenges. High
amounts of Cry j 1-specific IgE antibody were not de-
tected in the sera collected from Groups 2A, 2B and
2C. A distinct contrast was seen after sensitization
and challenge with Cry j 1 in Group 2D, in which the
Cry j 1-specific IgE level markedly increased until the
14th challenge.
DISCUSSION
We set out to determine whether nasal blockage is in-
duced in the murine Japanese cedar pollen-induced
allergic rhinitis model. In order to do this, B10.S mice
were sensitized by multiple intranasal instillations
with either a pollen extract + Al(OH)3 or Cry j 1 +
Al(OH)3, and then repetitively challenged by intrana-
sal application with either the pollen suspension or
Pollen-Induced Murine Allergic Rhinitis
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Fig. 3 Induction of sneezing after the 1st, 5th, 8th and 13th chalenges with either Japa-
nese cedar polen suspension (Groups 2A and 2C) or Cry j 1 (Groups 2B and 2D) in mice 
sensitized with either the polen extract＋ Al(OH)3 (Groups 2A and 2B) or Cry j 1＋ 
Al (OH)3 (Groups 2C and 2D). Each column represents the mean ± S.E. of 7―14 animals. 
＊ p＜ 0.05, ＊＊ p＜ 0.01 and ＊＊＊ p＜ 0.001 vs. Group NS-NC, † p＜ 0.05 and 
† † † p＜0.001 vs. Group NS-C.
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Cry j 1. The serum Cry j 1-specific IgE level was
clearly elevated only in the group sensitized by Cry j
1 + Al(OH)3 and then challenged by Cry j 1. No
changes were found for groups which were sensi-
tized by pollen extract + Al(OH)3 and then challenged
by the pollen suspension. However, the sneezing fre-
quency immediately increased after the challenges in
all of the sensitized-challenged groups. Nevertheless,
there were no antigen-induced increases in the sRaw
detected in any of the groups at any time point during
the 8 hour period following the challenges. Although
all groups including the negative control group
showed an increase in sRaw 20 minutes after the 15th
challenge, it is not clear why the antigen-independent
response was induced. These results suggest that
Cry j 1 may be more effective than crude antigens
when trying to efficiently sensitizechallenge mice.
However, even in mice that possessed both high
amounts of Cry j 1-specific IgE in the sera and exhib-
ited sneezing, there were no increases in the sRaw.
The results of the present murine study contrast
with those observed in the cedar pollen-induced
guinea pig allergic rhinitis study, in which guinea
pigs produced a large amount of allergen-specific IgE
after intranasal sensitizations with the pollen extract +
Al(OH)3 with the same dosage used in Group 1A.1,2
Moreover, the sensitized guinea pigs clearly showed
not only immediate sneezing but also biphasic nasal
blockage after pollen challenges.2-6 These observa-
tions suggest that mice are less sensitive to the pollen
allergen than guinea pigs, and that guinea pigs may
be susceptible to developing pollen-induced nasal
blockage. On the other hand, the sneezing frequency
of sensitized-challenged mice decreased on the 13th
challenge in comparison with the response on the 8th
challenge. However, because sneezing was induced
even after the 20th challenge with almost identical
frequency to that on the 13th challenge (data not
shown), sensitized-challenged mice may have not ac-
quired tolerance to the antigen.
sRaw is measured by using a double-flow plethys-
mography that detects both the nasal and thoracic
airflows.25 The nasal flow lags behind the thoracic
flow by several milliseconds, a delay which is affected
by the airway resistance. Therefore, when airway ob-
struction occurs, the delay is expanded.26 sRaw,
therefore, can be calculated based on this theory.26
Because the double-flow plethysmography allows us
to longitudinally measure the airway mechanics with-
out having to use any anesthesia or perform any sur-
gical operations, it has been used as a reliable pa-
rameter for measuring airway resistance.2-6 Since the
sRaw reflects changes in both the upper and lower
airways, we decreased the volume (2 μlnostril) of
the intranasally instilled antigen suspensions or solu-
tion as much as possible in order to restrict the aller-
gic site to the upper airway tissues. Thus, we believe
that the changes in the sRaw in the present model re-
flect the nasal blockage response. Therefore, the lack
of any increase in sRaw strongly indicates that nasal
blockage was not induced even in Group D mice
which were sensitizedchallenged with Cry j 1.
Miyahara et al.15,16 reported that when BALBc
mice sensitized by intraperitoneal administration of
OVA were challenged by intranasal application of
OVA 3 or 6 times, nasal blockage was immediately in-
Ogita-Nakanishi H et al.
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Fig. 4 Time-course changes in specific airway resistance (sRaw) after the 1st (A, B, C and D), 
5th (E, F, G and H) and 15th (I, J, K and L) chalenges with either Japanese cedar polen suspen-
sion (Groups 2A and 2C) or Cry j 1 (Groups 2B and 2D) in mice sensitized with either the polen ex-
tract＋ Al (OH)3 (Groups 2A and 2B) or Cry j 1＋ Al(OH)3 (Groups 2C and 2D). Each point 
represents the mean ± S.E. of 5―10 animals.
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duced and could be observed for up to 24 hours after
the challenge. In their study, however, they meas-
ured the nasal airway resistance under artificial venti-
lation from the larynx toward the nostril in systemi-
cally anesthetized mice.15,16 Therefore, several differ-
ences exist between the previous results and our cur-
rent study, including (1) antigen (species and dos-
age), (2) mouse strain, (3) sensitizationchallenge
protocol and (4) methods for measurement of airway
resistance. Since we could not determine the exact
reasons as to why we were not able to detect nasal
blockage in our model, further studies are required
in order to confirm the present results.
Although sneezing was induced in all of the sensi-
tized groups, Cry j 1-specific IgE production only oc-
curred after a challenge with Cry j 1 in Group 2D
mice. In our guinea pig models of allergic rhinitis2-6
and asthma,27-29 both of which were developed by lo-
cal and not systemic sensitizationchallenge, inci-
dences of allergic airway responses were induced
Pollen-Induced Murine Allergic Rhinitis
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Fig. 5 Time-course changes in amount of Cry j 1-specific 
IgE during chalenges with either Japanese cedar polen sus-
pension (Groups 2A and 2C) or Cry j 1 (Groups 2B and 2D) 
in mice sensitized with either polen extract＋ Al (OH)3 
(Groups 2A and 2B) or Cry j 1＋ Al (OH)3 (Groups 2C and 
2D). Each point represents the mean ± S.E. of 6―9 animals.
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even when serum antigen-specific IgE had not fully
increased.2,27 In our models, animals were sensitized
locally, as we believe that local sensitization is advan-
tageous in that it provides an antigen invasion route
that is identical to that seen in clinical settings. We
believe this advantage outweighs the model’s disad-
vantage of requiring a much longer time to fully sen-
sitize experimental animals. Our present results sug-
gest that local sensitization was established within
the nasal tissues after multiple antigen applications
which led to the diffusion of antigen-specific IgE into
the circulation.
Overall, nasal blockage was not induced in the
Japanese cedar pollen-induced allergic rhinitis model
in B10.S mice, even in animals possessing high
amounts of Cry j 1-specific IgE and showing signs of
sneezing.
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